Alfa Aesar joins Thermo Fisher Scientific

Published: 1-Oct-2015
Ingredients Finance

Johnson Matthey completes the £256m transaction to sell its research chemicals business to US life science supplier


Alfa Aesar is now part of Thermo Fisher Scientific following the completion of Johnson Matthey's cash £256m sale of the research chemicals business.

The transaction was first announced on 25 June.

Alfa Aesar is a supplier of more than 46,000 speciality chemicals to both industry and academic institutions in small-scale research quantities.

Commenting on the deal, Robert MacLeod, Chief Executive of Johnson Matthey, said: 'The divestment of the research chemicals business is a further step in delivering our long-term strategy to focus the group on growth areas where we can apply our expertise in complex chemistry to create long term value for our shareholders.'

  • Companies:
  • Johnson Matthey
  • Thermo Fisher Scientific
See more

You may also like

Manufacturing

Thermo Fisher Scientific Expands OSD development and manufacturing capabilities across North America

Read more
Additions to sites in Cincinnati, Ohio and Bend broaden early development capabilities to help accelerate preclinical oral drug product innovation and advanced drug delivery

Trending Articles

  1. Merck attains $588m global license for PD-1/VEGF bispecific antibody from LaNova Medicines The bispecific antibody is designed for oncological indications and functions by inhibiting the PD-1/PD-L1 and the VEGF/VEGFR receptor signalling pathways
  2. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  3. Shasun Chemicals and Drugs Limited
  4. Calibre Scientific acquires DCS to boost immunohistochemistry portfolio The acquisition expands Calibre's immunohistochemistry product and service portfolio across the BACH region
  5. Calibre Scientific acquires RUWAG, a Swiss provider of diagnostics and life sciences products and services Calibre Scientific is pleased to announce the acquisition of RUWAG Handels AG, a provider of diagnostics and life sciences products and services, selling to hospitals, private labs, universities and pharmaceutical companies in Switzerland

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Manufacturing

Thermo Fisher Scientific Expands OSD development and manufacturing capabilities across North America

Additions to sites in Cincinnati, Ohio and Bend broaden early development capabilities to help accelerate preclinical oral drug product innovation and advanced drug delivery
Hi Tech Manufacturing

Johnson Matthey agrees to sell Medical Device Components business

The business has been sold to Montagu Private Equity for USD $700m
Ingredients

Thermo Fisher Scientific launches next-generation Invitrogen TaqMan Cells-to-CT Express Kit with simplified, more sustainable workflow

With the Cells-to-CT Express Kit, researchers can measure relative gene expression while skipping the traditional RNA purification step when performing RT-qPCR
Ingredients

Multi-Attribute Method (MAM) for quality control in therapeutic proteins manufacturing

Therapeutic proteins are a unique class of large molecule drugs that have far more complex structures than the small molecule drugs
Finance

Thermo Fisher and Symphogen continue biopharma collaboration

Since the collaboration began in 2018, Symphogen has adopted updated instruments and software aimed to improve data quality and processes
Manufacturing

Moderna and Thermo Fisher sign long-term manufacturing agreement

Thermo Fisher will provide dedicated capacity for fill-finish services, in addition to inspection, labelling and packaging
Finance

Thermo-Fisher adds Russia-based sales team

The change also provides customers in Russia with a connection to the wider customer community for peer-to-peer support, the company says
Subscribe now